The estimated Net Worth of John B Rhodes is at least $3.52 Тысяча dollars as of 1 June 2018. John Rhodes owns over 7,500 units of Tonix Pharmaceuticals Corp stock worth over $3,521 and over the last 12 years John sold TNXP stock worth over $0.
John has made over 6 trades of the Tonix Pharmaceuticals Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently John bought 7,500 units of TNXP stock worth $24,975 on 1 June 2018.
The largest trade John's ever made was buying 25,000 units of Tonix Pharmaceuticals Corp stock on 31 October 2016 worth over $3,750. On average, John trades about 4,568 units every 53 days since 2013. As of 1 June 2018 John still owns at least 23,470 units of Tonix Pharmaceuticals Corp stock.
You can see the complete history of John Rhodes stock trades at the bottom of the page.
John's mailing address filed with the SEC is C/O TONIX PHARMACEUTICALS HOLDING CORP., 509 MADISON AVENUE, SUITE 1608, NEW YORK, NY, 10022.
Over the last 12 years, insiders at Tonix Pharmaceuticals Corp have traded over $155,884 worth of Tonix Pharmaceuticals Corp stock and bought 1,820,071 units worth $3,399,062 . The most active insiders traders include Ernest Mario, Seth Lederman и Bruce Daugherty. On average, Tonix Pharmaceuticals Corp executives and independent directors trade stock every 32 days with the average trade being worth of $2,734. The most recent stock trade was executed by Seth Lederman on 29 June 2022, trading 20,000 units of TNXP stock currently worth $34,200.
tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.
Tonix Pharmaceuticals Corp executives and other stock owners filed with the SEC include: